Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cordero

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for NeuroblastomaA Garaventa, B De Bernardi, C Pianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 childrenG P Tonini, L Boni, A Pession, et al.
Tumori|April 30, 1982
The outcome of Wilms' tumor in infants. Italy 1970-79G Pastore, L Cordero di Montezemolo, A Brach del Prever, et al.
Diabetes Technology & Therapeutics|October 10, 2018
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 DiabetesMichael A Wood, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics|January 31, 2017
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesSatish K Garg, Stuart A Weinzimer, William V Tamborlane, et al.
Diabetes Technology & Therapeutics|April 29, 2026
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 DiabetesHalis K Akturk, Laura M Nally, Rayhan A Lal, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Diabetes Technology & Therapeutics|March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal TrialRon Brazg, Satish K Garg, Anuj Bhargava, et al.
Diabetes Technology & Therapeutics|October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 DiabetesCatherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics|October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 DiabetesAnders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for NeuroblastomaA Garaventa, B De Bernardi, C Pianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 childrenG P Tonini, L Boni, A Pession, et al.
Tumori|April 30, 1982
The outcome of Wilms' tumor in infants. Italy 1970-79G Pastore, L Cordero di Montezemolo, A Brach del Prever, et al.
Diabetes Technology & Therapeutics|October 10, 2018
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 DiabetesMichael A Wood, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics|January 31, 2017
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesSatish K Garg, Stuart A Weinzimer, William V Tamborlane, et al.
Diabetes Technology & Therapeutics|April 29, 2026
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 DiabetesHalis K Akturk, Laura M Nally, Rayhan A Lal, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Diabetes Technology & Therapeutics|March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal TrialRon Brazg, Satish K Garg, Anuj Bhargava, et al.
Diabetes Technology & Therapeutics|October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 DiabetesCatherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics|October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 DiabetesAnders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
Pageof 18